Mountain Crest Acquisition Corp. V (MCAG): Operating Income

Annual figures by period end, from SEC filings.

-$471.8K
Year ended 2025-12-31
-$381.0K
Trailing 12 months to 2026-06-30
2022-12-31: -$746.9K2023-12-31: -$2.65M2024-12-31: -$618.5K2025-12-31: -$471.8K-$471.8K
2022-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$471.8Kn/m2026-03-16, From 2025-01-01
2024-12-31-$618.5Kn/m2026-03-16, From 2024-01-01
2023-12-31-$2.65Mn/m2025-04-01, From 2023-01-01
2022-12-31-$746.9Kn/a2024-08-26, From 2022-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Mountain Crest Acquisition Corp. V (MCAG)2025-12-31-$471.8Kn/m
Vycor Medical Inc (VYCO)2025-12-31$33.9Kn/m
Family Office of America, Inc. (FOFA)2025-12-31-$501.1Kn/m
Nuo Therapeutics, Inc. (AURX)2025-12-31-$2.52Mn/m
Vivos Inc (RDGL)2025-12-31-$3.17Mn/m
QHSLab, Inc. (USAQ)2025-12-31$131.2K-36.2%
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31-$6.92Mn/m
Sigyn Therapeutics, Inc. (SIGY)2024-12-31-$2.52Mn/m
PetVivo Holdings, Inc. (PETV)2026-03-31-$9.06Mn/m

Compare MCAG, VYCO, FOFA, AURX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗